| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 785,646 | 1,939,957 | 1,946,315 | 1,112,431 | | Cost of Revenue | 439,774 | 1,047,791 | 1,046,245 | 617,097 | | | Gross Profit | 345,872 | 892,166 | 900,070 | 495,334 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 401,081 | 630,289 | 584,721 | 464,726 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 29,507 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (55,209) | 232,370 | 315,349 | 30,608 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,676 | 22,273 | 12,170 | 891 | | Earnings Before Interest And Taxes | (49,533) | 254,643 | 327,519 | 31,499 | | Interest Expense | 15,917 | 28,918 | 20,411 | 16,566 | | Income Before Tax | (65,450) | 225,725 | 307,108 | 14,933 | | Income Tax Expense | (14,464) | 49,324 | 69,010 | 3,150 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (50,986) | 176,401 | 238,098 | 11,783 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (50,986) | 176,401 | 238,098 | 11,783 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($50,986) | $176,401 | $238,098 | $11,783 |
|
0.45% Nasdaq 
0.20%
Income Statement
